Clinical perspectives in inflammatory bowel disease

Australian and New Zealand Journal of Medicine

Volumn 26, Issue 1, 1996, Pages 15-19

  Selby, W ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; OLSALAZINE; SALAZOSULFAPYRIDINE;

AGE; CROHN DISEASE; ENTERITIS; HUMAN; ORAL DRUG ADMINISTRATION; PROGNOSIS; SHORT SURVEY; TOPICAL DRUG ADMINISTRATION; ULCERATIVE COLITIS;

EID: 0029983035     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1996.tb02901.x     Document Type: Short Survey

References (27)

1. Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994; 107: 3-11.
2. Stark ME, Tremaine WJ. Maintenance of symptomatic remission in patients with Crohn's disease. Mayo Clin Proc 1993; 68: 1183-90.
3. Rutgeerts P, Geboes K, Vantrappen G et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990; 99: 956-63.
4. Landi B, N'Guyen Ahn T, Cortot A et al. Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. Gastroenterology 1992; 102: 1647-53.
5. Fleischer DE, Grimm IS, Friedman LS. Inflammatory bowel disease in older patients. Med Clin North Am 1994; 78: 1303-19.
6. Selby WS. Current medical management of inflammatory bowel disease. J Gastroenterol Hepatol 1993; 8: 70-83.
7. Sutherland LR, May GR, Shaffer EA. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993; 118: 540-9.
8. Courtney MG, Nunes DP, Bergin CF et al. Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis. Lancet 1992; 339: 1279-81.
9. Porro GB, Ardizzone S, Petrillo M et al. Low Pentasa dosage versus hydrocortisone in the topical treatment of active ulcerative colitis: a randomized, double-blind study. Am J Gastroenterol 1995; 90: 736-9.
10. Trallori G, Messori A, Scuffi C et al. 5-aminosalicylic acid enemas to maintain remission in left-sided ulcerative colitis: a meta- and economic analysis. J Clin Gastroenterol 1995; 20: 257-9.
11. Spencer CM, McTavish D. Budesonide: a review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease. Drugs 1995; 50: 854-72.
12. Hawthorne AB, Logan RFA, Hawkey CJ et al. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. Br Med J 1992; 305: 20-2.
13. Lichtiger S, Present DH, Kornbluth A et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330: 1841-5.
14. Pullan RD, Rhodes J, Ganesh S et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994; 330: 811-5.
15. Thomas GA, Rhodes J, Mani V et al. Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl J Med 1995; 332: 988-92.
16. Singleton JW, Hanauer SB, Gitnick GL et al. Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial. Gastroenterology 1993; 104: 1293-301.
17. Steinhart A, Hemphill D, Greengerg GR. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis. Am J Gastroenterol 1994; 89: 2116-24.
18. Arber N, Odes S, Fireman Z et al. A controlled double blind multicenter study of the effectiveness of 5-amino-salicylic acid in patients with Crohn's disease in remission. J Clin Gastroenterol 1995; 20: 203-6.
19. McLeod RS, Wolff BG, Steinhart AH et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995; 109: 404-13.
20. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn's disease. A meta-analysis. Ann Intern Med 1995; 122: 132-42.
21. Candy S, Wright J, Gerber M et al. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 1995; 37: 674-8.
22. Connell WR, Kamm MA, Dickson M et al. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994; 343: 1249-52.
23. Sandborn WJ. Cyclosporine therapy for inflammatory bowel disease: definitive answers and remaining questions. Gastroenterology 1995; 1001-3.
24. Feagan BG, Rochon J, Fedorak RN et al. Methotrexate for the treatment of Crohn's disease. N Engl J Med 1995; 332: 292-7.
25. Rutgeerts P, Hiele M, Geboes K et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995; 108: 1617-21.
26. Graham DY, Al-Assi, Robinson M. Prolonged remission in Crohn's disease following therapy for Mycobacterium paratuberculosis infection. Gastroenterology 1995; 108: A826.
27. Fazio VW, Tjandra JJ, Lavery IC. Long-term follow up of strictureplasty in Crohn's disease. Dis Colon Rectum 1993; 36: 355-61.